STAT+: Pharmalittle: WHO scientist resigns amid shake-up; FDA considers over-the-counter naloxone

Top of the morning to you. The middle of the week is upon us and, since you made it this far, why not forge ahead? After all, there is always light at the end of the proverbial tunnel. You never know what you may accomplish. So please join us as we celebrate this notion with a cup or three of delicious stimulation. (We are foraging for something appropriate since we are on the road.) Meanwhile, we have assembled the latest menu of tidbits to help you along. So please dig in. Have a smashing day and please feel free to forward any secrets you come across. Our “in basket” is always open…

The chief scientist at the World Health Organization says she is leaving the agency, the first of a series of high-profile departures expected at the global health body as it prepares for a post-pandemic future, Reuters writes. The exit of Soumya Swaminathan, an Indian pediatrician, comes as the second term of WHO Director-General Tedros Adhanom Ghebreyesus as leader of the 74-year-old global health agency gets underway. Swaminathan did not offer a reason. Others leaving include Ren Minghui, assistant director for universal health coverage and communicable and non-communicable disease, and Mariângela Batista Galvão Simão, head of access to medicines.